. 2005 Feb;15(1):27–41. doi: 10.1055/s-2005-868161

Table 2.

Literature Evaluating the Efficacy of Revascularization for the Treatment of Hemorrhagic Moyamoya Disease

Report	Patient #	Method	F/U (mean)	Result	Conclusion
Houkin et al³⁵ (1996)	24	Single institution; All underwent STA-MCA bypass + EDAMS	6.4 years	25% decrease in moyamoya vessels; 12.5% rebleed	Rebleed risk may be reduced by surgery
Iwama et al³⁶ (1997)	45	Single institution; Bypass: 43, No bypass: 2	3.7 years	60% decrease in moyamoya vessels; 20% rebleed (postop)	Rebleed risk may be reduced by surgery
Fujii et al³⁷ (1997)	290	Multicenter retrospective study; Bypass: 152, No bypass: 138	?	Bypass: 19.1% rebleed No bypass: 28.3% rebleed	Rebleed risk may be reduced by surgery
Okada et al³⁸ (1998)	15	Single institution; All underwent STA-MCA bypass	7.8 years	60% decrease in moyamoya vessels; 6.7% perioperative bleed; 20% rebleed	Rebleed risk may be reduced by surgery
Yoshida et al³⁹ (1999)	28	Single institution; Revascularization: 10, No revascularization: 18	14.2 years	Revascularization: 12.5% rebleed No revascularization: 38.5% rebleed	Rebleed risk may be reduced by surgery
Kawaguchi et al⁴⁰ (2000)	22	Single institution; STA-MCA bypass: 6, EDAS: 5, No revascularization:11	8 years	STA-MCA bypass: 0% recurrent stroke EDAS: 60% recurrent stroke No revascularization: 54% recurrent stroke	Rebleed risk reduced by bypass (p < 0.05)